Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-iv

Active Publication Date: 2006-11-16
SINO MED INT ALLIANCE
View PDF70 Cites 25 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

[0012] The invention is also directed to a method of treating a malcondition that can be regulated or normalized via inhibition of DPP-IV. The method involves administration of an effective amount of a pyrrolidine compound of the invention, such as would be present in a pharmaceutical composition of the invention, to mammals, especially humans, to affect a malcondition that can be regulated or normalized via inhibition of DPP-IV. Preferably, an effective amount of

Problems solved by technology

This proposal has significant difficulties, however.
Thus, the difficulty concerning inhibitors of DPP-IV is that they can also affect the other members of the enzyme group.
The evidence indicates that, for example, other inhibitors of DPP-IV, which also inhibit the other amino-dipeptidases such as DPP-VIII, will cause toxic effects in animals.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-iv
  • Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-iv
  • Pyrrolidine compounds and methods for selective inhibition of dipeptidyl peptidase-iv

Examples

Experimental program
Comparison scheme
Effect test

example 1

Synthesis of Pyrrolidine Boronic Acid Compounds

[0120] Unless otherwise noted, materials were obtained from commercial suppliers and used without further purification. 1H NMR spectra were determined on a Bruker Avance 300 spectrometer. Chemical shifts are expressed in ppm downfield from internal tetramethylsilane. Mass spectra were obtained on a Finnigan LCQ mass spectrometer with ESI source.

[0121] THF and ethyl ether were distilled from sodium / benzophenone ketyl. Dichloromethane was dried by distillation from phosphorus pentoxide.

[0122] Preparation of compound 2: To a solution of 1 (100.0 g, 0.97 mol) in dichloromethane (1000 mL) was added triethyl amine (134 mL, 0.97 mol) dropwise. After being stirred for 30 min, benzaldehyde (102.8 g, 0.97 mol) was added, followed by the addition of MgSO4 (232.0 g, 1.97 mol). The mixture was stirred overnight. After filtration, the filtrate was evaporated to give compound 2 (150.0 g, 81.1%). 1H NMR (CDCl3): δ 1.52 (m, 3H), 3.74 (s, 3 H), 4.15-...

example 2

Synthesis of Ethyl-Substituted Pyrrolidine Boronic Acid Compounds

[0136]

[0137] Preparation of compound 15: To a solution of 2-amino-butyric acid (50 g, 0.48 mol) in MeOH (300 mL) at 0° C. was added thionyl chloride (66.7 g, 0.57 mol) dropwise. After stirring for 2 h, the reaction was concentrated and the precipitated solid was washed with diethyl ether to afford product 15 (63.0 g, 85.1%). 1H NMR (DMSO): δ0.85-0.92 (m, 3 H), 1.86-2.0 (m, 2 H), 3.73 (s, 3 H), 3.91-4.12 (m, 1H), 8.40-8.54 (br, 3H).

[0138] Preparation of compound 16: To a solution of 15 (40.9 g, 0.27 mol) in dichloromethane (600 mL) was added dropwise triethyl amine (39 mL, 0.32 mol). After being stirred for 30 min, benzaldehyde (28.3 g, 0.27 mol) was added, followed by the addition of MgSO4 (97.2 g, 0.81 mol). The mixture was stirred overnight. After filtration, the filtrate was evaporated to give compound 16 as a red oil (52.0 g, 94.9%). 1H NMR (CDCl3): δ 0.88 (t, 3H), 1.86-2.0 (m, 2H), 3.68 (s, 3 H), 3.83-3.88( m, 1...

example 3

Synthesis of Additional R-Substituted Pyrrolidine Compounds

[0163] Using the procedures disclosed for examples 1 and 2, additional R-substituted pyrrolidine compounds can be prepared. To begin, the 2-amino, 2-R-substituted acetic acid ester starting material is used. The synthetic scheme is as follows. If an amine group is present in R, it is protected in a manner like that for protection of the left side pyrrolidine ring nitrogen depicted in scheme 6 and also as in Examples 1 and 2.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Fractionaaaaaaaaaa
Login to view more

Abstract

The present invention is directed to pyrrolidinylaminoacetyl pyrrolidine boronic acid compounds that display selective, potent dipeptidyl peptidase IV (DPP-IV) inhibitory activity. These compounds are useful for the treatment of disorders that can be regulated or normalized via inhibition of DPP-IV including those characterized by impaired glycemic control such as Diabetes Mellitus and related conditions. The compounds can be administered alone or with another medicament that displays pharmacological activity for treatment of these and other diseases.

Description

CROSS REFERENCE TO RELATED APPLICATIONS [0001] This application is a continuation-in-part of U.S. application Ser. No. 10 / 514,575, filed on Nov. 12, 2004, which is a national stage application of PCT / US04 / 037820, which claims priority to U.S. provisional application No. 60 / 519,566, filed on Nov. 12, 2003, U.S. provisional application No. 60 / 557,011, filed on Mar. 25, 2004, and U.S. provisional application No. 60 / 592,972, filed on Jul. 30, 2004. This application is also a continuation-in-part of U.S. Application No. 60 / 676,808, filed on May 2, 2005. These applications are incorporated herein by reference.FIELD OF THE INVENTION [0002] The present invention relates to pyrrolidinylaminoacetyl pyrrolidine boronic acid compounds and their use as selective inhibitors of post-proline / alanine cleaving amino-dipeptidases, particularly dipeptidyl peptidase-IV (DPP-IV). The invention also relates to methodology for employing such pyrrolidine compounds, alone or with another medicament, to treat...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/69C07F5/02
CPCC07F5/025
Inventor CAMPBELL, DAVID ALANWINN, DAVID T.BETANCORT, JUAN MANUEL
Owner SINO MED INT ALLIANCE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap